Article Details
Retrieved on: 2025-08-16 18:02:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Acumen's monoclonal antibody, Sabirnetug, shows high selectivity for toxic Amyloid Beta oligomers, which could lead to greater clinical efficacy ...
Article found on: www.ainvest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here